Quidel Corporation - News Releases

2021 2020 2019 2018 2017 2016 2015 2014

07/26/2021

Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter

07/19/2021

State of Delaware Selects Quidel for COVID-19 Testing Program at Schools

07/14/2021

Quidel to Hold Fiscal Second Quarter 2021 Financial Results Conference Call on August 5th, 2021

07/12/2021

Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel

07/12/2021

New Website Created by Quidel Corporation Provides Consumers With Information and Easy-to-Understand Answers Regarding Lyme Disease

06/29/2021

Public Service Campaign From Quidel Corporation Directed Toward Heightening Awareness Among Summer Camps of the Dangers of Lyme Disease

06/24/2021

With Lyme Disease on the Rise Nationwide, Quidel Corporation Urges Early Testing With Its Rapid Point-of-Care Test

06/11/2021

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device

06/10/2021

Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021

05/24/2021

Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference

05/24/2021

Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing

05/14/2021

Quidel’s QuickVue® At-Home OTC COVID-19 Test Now Available for Sale Through Amazon

05/06/2021

Quidel Reports First Quarter 2021 Financial Results

05/05/2021

Quidel Forms Retail Collaboration With Walgreens for Over-the-Counter Sale of QuickVue® At-Home OTC COVID-19 Tests

05/04/2021

Quidel to Present Virtually at the BofA Securities 2021 Health Care Conference

04/27/2021

Teaching Doctors Nationwide How to Recognize and Differentiate Between Lyme Disease, COVID-19 and the Flu in Quidel-Hosted May 5 Webinar

04/26/2021

Quidel to Hold Fiscal First Quarter 2021 Financial Results Conference Call on May 6th, 2021

04/22/2021

Quidel Signs Retail Distribution Agreement to Increase Access to At-Home COVID-19 Testing

04/22/2021

Quidel Announces Preliminary Revenue for First Quarter 2021

04/13/2021

Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease

04/05/2021

Start of Lyme Disease Season Provides Heightened Risks for Americans Wanting to Go Outdoors After a Year of COVID-19 Restrictions

04/01/2021

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

04/01/2021

Quidel Partners With San Diego Padres Organization for COVID-19 Testing

03/31/2021

Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing

03/31/2021

Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing

03/18/2021

Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing

03/01/2021

Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test

02/22/2021

Quidel to Present at Upcoming Conferences

02/18/2021

Quidel Reports Fourth Quarter and Full Year 2020 Financial Results

02/03/2021

Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19

01/28/2021

Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021

01/07/2021

Quidel Announces Preliminary Revenue for Fourth Quarter 2020; Will Present Virtually at 39th Annual J.P. Morgan Healthcare Conference